Our latest #WhiteheadPostdocProfiles features Christoph Gäbelein, a postdoc in the Lehmann lab studying how oocytes avoid the effects of aging during their long dormancies: https://lnkd.in/ej_UuyuP
Whitehead Institute
Research Services
Cambridge, Massachusetts 11,302 followers
A world-renowned non-profit research institution dedicated to improving human health through basic biomedical research
About us
Whitehead Institute for Biomedical Research is a leading, nonprofit research and educational institution that has defined the cutting edge of biomedical science, creating a legacy of research excellence and academic eminence since 1982. Wholly independent in its governance, finances and research programs, Whitehead shares a teaching affiliation with Massachusetts Institute of Technology, offering the intellectual, collegial and scientific benefits of a leading research university. Whitehead provides scientists with the resources and freedom to follow their scientific instincts, form novel collaborations and conduct high-risk research. While probing basic biological processes, 14 faculty Members and 6 Fellows develop innovative technologies and lay the foundation for projects that improve human health. They run pioneering programs in cancer research, immunology, developmental biology, stem cell research, regenerative medicine, genetics and genomics—programs with a record of success.
- Website
-
http://www.wi.mit.edu
External link for Whitehead Institute
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Nonprofit
- Founded
- 1982
- Specialties
- biomedical Research, cancer research, immunology, developmental biology, stem cell research, regenerative medicine, genetics, genomics, evolution, protein funtion, and RNA
Locations
-
Primary
Get directions
455 Main St
Cambridge, Massachusetts 02142, US
Employees at Whitehead Institute
Updates
-
In Whitehead Institute's 2024 Annual Report, learn about pioneering research to address global challenges, from chronic and infectious diseases to climate change: https://lnkd.in/eH7gxc_M
-
-
"My time with her made me realize just how beautiful and fun math is, and I could see its practical applications in everyday life, all around me," graduate student Neha Bokil says. #DayintheLab Full video: https://lnkd.in/ed5RXgTX
-
"Pigeon pea provides a key source of nutrition for about a billion people worldwide, but there isn’t much known about it," postdoc Sonia Boor says. #WhiteheadPostdocProfiles https://lnkd.in/eZRmBQqc
-
-
In regenerating planarians, stem cell fate choice is highly heterogeneous, with adjacent stem cells choosing different fates. Here, a powerful visualization method called MERFISH detects hundreds of different transcripts at a single-cell resolution. Credit to Chan Park. #WhiteheadWonders
-
-
It's here! Inside our 2024 Annual Report, learn how science at Whitehead Institute bridges the gap between discovery and solutions to complex global challenges: https://lnkd.in/eH7gxc_M
-
-
"If you only consider a static picture of a protein or a cell, you miss out on discovering these changes that only appear when molecules are in motion," graduate student Shannon Moreno says. Cellular traffic congestion in chronic disease suggests new therapeutic targets: https://lnkd.in/eTNgTMbg
-
-
"Torpor as a behavior appears in many unrelated mammals and birds. Part of our research is understanding why these different capacities exist," postdoc Christopher Reid says. #WhiteheadPostdocProfiles https://lnkd.in/eMVqU-nq
-
-
"I’m excited about what this work could mean for patients. My hope is that this will lead to a new class of drugs that restore protein mobility," postdoc Alessandra Dall’Agnese says. https://lnkd.in/eTNgTMbg
Cellular traffic congestion in chronic diseases suggests new therapeutic targets | Whitehead Institute
wi.mit.edu